Announced
Financials
Sources
Tags
Private Equity
Friendly
pharmaceutical company
Domestic
Acquisition
France
Minority
Pending
Private
Pharmaceuticals
Single Bidder
Synopsis
CAPZA, an established European private investment platform, agreed to acquire a stake in Nutravalia, an operator of a pharmaceutical company, for $95m. “We were attracted by Nutravalia’s development project, which has created two expert and highly specialised brands that have become major players in their respective markets in just a few years. We believe in the Group’s strong growth potential, both in France and internationally, and we are proud to support Samuel, Michel and their teams in this new stage of the Group’s development," Maxence Radix, CAPZA Managing Partner.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.